These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19801101)

  • 21. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
    Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
    Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Optimal dosing schedule in combination therapy with irinotecan and doxifluridine in a human colorectal cancer xenograft model].
    Yanagisawa M; Ishikawa T; Ouchi KF; Tanaka Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):223-30. PubMed ID: 12610870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells.
    Shelton JW; Waxweiler TV; Landry J; Gao H; Xu Y; Wang L; El-Rayes B; Shu HK
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):469-76. PubMed ID: 23540347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines.
    Guérin O; Etienne-Grimaldi MC; Monteverde M; Sudaka A; Brunstein MC; Formento P; Lattanzio L; Maffi M; Tonissi F; Ortholan C; Pagès G; Fischel JL; Lo Nigro C; Merlano M; Milano G
    Urol Oncol; 2013 Nov; 31(8):1567-75. PubMed ID: 22608542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
    Miki T; Sawada M; Nonomura N; Kojima Y; Okuyama A; Maeda O; Saiki S; Kotake T
    Eur Urol; 1997; 31(1):92-6. PubMed ID: 9032542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth.
    Takano S; Kamiyama H; Mashiko R; Osuka S; Ishikawa E; Matsumura A
    J Neurooncol; 2010 Sep; 99(2):177-85. PubMed ID: 20066473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of irinotecan in colorectal cancer.
    Saltz LB
    Curr Oncol Rep; 1999; 1(2):155-60. PubMed ID: 11122813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.
    Kawato Y; Furuta T; Aonuma M; Yasuoka M; Yokokura T; Matsumoto K
    Cancer Chemother Pharmacol; 1991; 28(3):192-8. PubMed ID: 1855276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effects with apoptotic death in human promyelocytic leukemia HL-60 cells and suppression of leukemia xenograft tumor growth by irinotecan HCl.
    Chen YL; Chueh FS; Yang JS; Hsueh SC; Lu CC; Chiang JH; Lee CS; Lu HF; Chung JG
    Environ Toxicol; 2015 Jul; 30(7):803-15. PubMed ID: 24474168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.
    Cesca M; Frapolli R; Berndt A; Scarlato V; Richter P; Kosmehl H; D'Incalci M; Ryan AJ; Giavazzi R
    Neoplasia; 2009 Nov; 11(11):1155-64. PubMed ID: 19881951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity.
    Williams KJ; Telfer BA; Brave S; Kendrew J; Whittaker L; Stratford IJ; Wedge SR
    Clin Cancer Res; 2004 Dec; 10(24):8587-93. PubMed ID: 15623642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irinotecan/thalidomide in metastatic colorectal cancer.
    Govindarajan R
    Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):23-6. PubMed ID: 12014864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of water soluble poly(L-glutamic acid)-camptothecin conjugate against resistant human lung cancer xenografted in nude mice.
    Zou Y; Wu QP; Tansey W; Chow D; Hung MC; Charnsangavej C; Wallace S; Li C
    Int J Oncol; 2001 Feb; 18(2):331-6. PubMed ID: 11172600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer.
    DeRosier LC; Buchsbaum DJ; Oliver PG; Huang ZQ; Sellers JC; Grizzle WE; Wang W; Zhou T; Zinn KR; Long JW; Vickers SM
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5535s-5543s. PubMed ID: 17875786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo.
    Pohl M; Stricker I; Schoeneck A; Schulmann K; Klein-Scory S; Schwarte-Waldhoff I; Hasmann M; Tannapfel A; Schmiegel W; Reinacher-Schick A
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1377-86. PubMed ID: 19340455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective use of vandetanib in the treatment of thyroid cancer.
    Fallahi P; Di Bari F; Ferrari SM; Spisni R; Materazzi G; Miccoli P; Benvenga S; Antonelli A
    Drug Des Devel Ther; 2015; 9():3459-70. PubMed ID: 26170630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models.
    Troiani T; Napolitano S; Martini G; Martinelli E; Cardone C; Normanno N; Vitagliano D; Morgillo F; Fenizia F; Lambiase M; Formisano L; Bianco R; Ciardiello D; Ciardiello F
    Clin Cancer Res; 2015 Sep; 21(18):4153-64. PubMed ID: 26019172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
    Choi S; Sano D; Cheung M; Zhao M; Jasser SA; Ryan AJ; Mao L; Chen WT; El-Naggar AK; Myers JN
    Clin Cancer Res; 2008 Aug; 14(16):5081-9. PubMed ID: 18698025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vandetanib is effective in EGFR-mutant lung cancer cells with PTEN deficiency.
    Takeda H; Takigawa N; Ohashi K; Minami D; Kataoka I; Ichihara E; Ochi N; Tanimoto M; Kiura K
    Exp Cell Res; 2013 Feb; 319(4):417-23. PubMed ID: 23274758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
    Yawata K; Osada S; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
    Anticancer Res; 2016 Oct; 36(10):5215-5226. PubMed ID: 27798882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.